REZOLUTE, INC. Debt Securities Available For Sale Excluding Accrued Interest
REZOLUTE, INC. (RZLT) had Debt Securities Available For Sale Excluding Accrued Interest of $97.19 million as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-09-24
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $97.19M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $109.03M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $120.99M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $143.10M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $97.19M 10-K · filed 2026-09-24 |
| 2026-03-31 | $109.03M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $120.99M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $143.10M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $73.75M 10-K · filed 2026-09-24 |
| 2025-03-31 | $73.81M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $96.38M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $107.35M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $56.74M 10-K · filed 2025-09-17 |
| 2024-03-31 | $75.67M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $83.45M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $98.82M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $102.33M 10-K · filed 2024-09-19 |
| 2023-03-31 | $95.53M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |